GB201602535D0 - Improved flu vaccine yield - Google Patents

Improved flu vaccine yield

Info

Publication number
GB201602535D0
GB201602535D0 GBGB1602535.5A GB201602535A GB201602535D0 GB 201602535 D0 GB201602535 D0 GB 201602535D0 GB 201602535 A GB201602535 A GB 201602535A GB 201602535 D0 GB201602535 D0 GB 201602535D0
Authority
GB
United Kingdom
Prior art keywords
flu vaccine
improved
vaccine yield
yield
improved flu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1602535.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Edinburgh
Original Assignee
University of Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Edinburgh filed Critical University of Edinburgh
Priority to GBGB1602535.5A priority Critical patent/GB201602535D0/en
Publication of GB201602535D0 publication Critical patent/GB201602535D0/en
Priority to PCT/GB2017/050329 priority patent/WO2017137753A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
GBGB1602535.5A 2016-02-12 2016-02-12 Improved flu vaccine yield Ceased GB201602535D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1602535.5A GB201602535D0 (en) 2016-02-12 2016-02-12 Improved flu vaccine yield
PCT/GB2017/050329 WO2017137753A1 (en) 2016-02-12 2017-02-09 Improved flu vaccine yield

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1602535.5A GB201602535D0 (en) 2016-02-12 2016-02-12 Improved flu vaccine yield

Publications (1)

Publication Number Publication Date
GB201602535D0 true GB201602535D0 (en) 2016-03-30

Family

ID=55697609

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1602535.5A Ceased GB201602535D0 (en) 2016-02-12 2016-02-12 Improved flu vaccine yield

Country Status (2)

Country Link
GB (1) GB201602535D0 (en)
WO (1) WO2017137753A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
ATE534731T1 (en) 2001-05-30 2011-12-15 Stratagene California COMPOSITIONS AND METHODS FOR RANDOM MUTAGENESIS OF NUCLEIC ACIDS
WO2007048089A2 (en) * 2005-10-17 2007-04-26 Medimmune, Llc Multi-plasmid system for the production of influenza virus
EP2233152A1 (en) * 2009-03-24 2010-09-29 Avir Green Hills Biotechnology Research Development Trade Ag High growth reassortant influenza A virus
CN102304495A (en) * 2011-09-08 2012-01-04 中国农业科学院上海兽医研究所 Recombinant influenza virus capable of expressing HA (hemagglutinin) protein with high efficiency and preparation method and application thereof
AU2013354219A1 (en) * 2012-12-03 2015-07-02 Novartis Ag Reassortant influenza a viren

Also Published As

Publication number Publication date
WO2017137753A1 (en) 2017-08-17

Similar Documents

Publication Publication Date Title
HK1244034A1 (en) Tri-segmented arenaviruses as vaccine vectors
DK3393510T3 (en) ZIKAVIRUS VACCINE
DK3134131T3 (en) Nucleic acid vaccines
GB201410971D0 (en) Vaccine
GB201518684D0 (en) Vaccine
PL3185899T3 (en) Improved hvt-vectored nd-ibd vaccine
SG11201707926WA (en) Streptococcal vaccine
AU361067S (en) Collar design
GB201522132D0 (en) Vaccine
SG11201701279VA (en) Alkylated influenza vaccines
GB201506041D0 (en) Avian vaccine
GB201616904D0 (en) Vaccine
EP3423090C0 (en) Novel influenza antigens
GB201608821D0 (en) Vaccines
PT3188755T (en) Vaccine
GB201417214D0 (en) Vaccine
GB201602535D0 (en) Improved flu vaccine yield
GB201419061D0 (en) Conjugated Vaccine
ZA201807035B (en) Reoviridae vaccine
GB201712904D0 (en) Vaccine
GB201704126D0 (en) Vaccine
GB201703809D0 (en) Vaccine
GB201603029D0 (en) Vaccine
GB201707785D0 (en) Vaccination
GB201614387D0 (en) Improved vaccines

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)